ABT-869, a multi-targeted tyrosine kinase inhibitor, in combination with rapamycin is effective for subcutaneous hepatocellular carcinoma xenograft (Q46310541)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | ABT-869, a multi-targeted tyrosine kinase inhibitor, in combination with rapamycin is effective for subcutaneous hepatocellular carcinoma xenograft |
scientific article |
Statements
1 reference
ABT-869, a multi-targeted tyrosine kinase inhibitor, in combination with rapamycin is effective for subcutaneous hepatocellular carcinoma xenograft (English)
1 reference
Viraj J Jasinghe
1 reference
Zhigang Xie
1 reference
Jianbiao Zhou
1 reference
Jiaying Khng
1 reference
Lai-Fong Poon
1 reference
Palaniyandi Senthilnathan
1 reference
Keith B Glaser
1 reference
Daniel H Albert
1 reference
Steven K Davidsen
1 reference
Chien-Shing Chen
1 reference
1 October 2008
1 reference
1 reference
49
1 reference
6
1 reference
985-997
1 reference
Identifiers
1 reference